CAS 933-87-9

5-bromo-1-methyl-4-nitro-1H-imidazole

Description:

5-Bromo-1-methyl-4-nitro-1H-imidazole is a heterocyclic organic compound characterized by its imidazole ring, which is a five-membered aromatic structure containing two nitrogen atoms. The presence of a bromine atom at the 5-position and a nitro group at the 4-position contributes to its unique chemical properties. This compound is typically a yellow to orange solid and is soluble in organic solvents. It exhibits notable reactivity due to the electron-withdrawing nature of the nitro group, which can influence its behavior in various chemical reactions, including nucleophilic substitutions and electrophilic aromatic substitutions. The methyl group at the 1-position can also affect its steric and electronic properties. 5-Bromo-1-methyl-4-nitro-1H-imidazole is of interest in medicinal chemistry and may serve as a precursor or intermediate in the synthesis of pharmaceuticals or agrochemicals. Its CAS number, 933-87-9, is a unique identifier that facilitates its identification in chemical databases and regulatory frameworks.

Formula: C₄H₄BrN₃O₂

InChI: InChI=1/C4H4BrN3O2/c1-7-2-6-4(3(7)5)8(9)10/h2H,1H3

SMILES: Cn1cnc(c1Br)N(=O)=O

Synonyms:

• 1H-imidazole, 5-bromo-1-methyl-4-nitro-
• 5-Bromo-1-methyl-4-nitro-1H-imidazole

5-Bromo-1-methyl-4-nitro-1H-imidazole

CAS: 933-87-9

Formula: C₄H₄BrN₃O₂

Purity: 97%

Color and Shape: Solid

Molecular weight: 205.9975

Ref: IN-DA006G70

5-Bromo-1-methyl-4-nitro-1H-imidazole

CAS: 933-87-9

5-Bromo-1-methyl-4-nitro-1H-imidazole

Purity: 95%

Molecular weight: 206g/mol

Ref: 54-OR1004750

5-Bromo-1-methyl-4-nitro-1H-imidazole

CAS: 933-87-9

Formula: C₄H₄BrN₃O₂

Purity: 97%

Molecular weight: 205.999

Ref: 10-F228322

5-Bromo-1-methyl-4-nitro-1H-imidazole

CAS: 933-87-9

5-Bromo-1-methyl-4-nitro-1H-imidazole is a nitroimidazole compound that has been shown to have antibacterial activity against gram-positive and gram-negative bacteria. The mechanism of action of this drug is not fully understood, but it is thought to be due to the ability of the drug to act as a substrate for bacterial nitroreductase enzymes, which are involved in nitrogen metabolism. 5BrNMI also inhibits DNA gyrase and topoisomerase IV and may inhibit cell wall synthesis. 5BrNMI can be used as an alternative treatment for infections caused by staphylococci or epidermidis.

Formula: C₄H₄BrN₃O₂

Purity: Min. 95%

Molecular weight: 206 g/mol

Ref: 3D-AAA93387